We provide an equity analysis subscription service designed to help you save time and catch more runners more consistently. See our offerings here.
- Based in Vancouver Canada, Arbutus Biopharma is a clinical-stage biotech, focused on discovering, developing and commercializing a cure for people with chronic hepatitis B virus (“HBV”) infection
- For an overview of ABUS HBV pipeline including a P2 asset, click here
- The company has several partnerships; Genevant, Gritstone (one of our favorites GRTS), Alynlam, and Marqibo
- For an overview of leadership, board of directors and scientific advisory, click here